Implant Sciences Announces Air Cargo Screening Pilot Program
Implant Sciences Corporation (OTCPK:IMSC), a high technology supplier of
systems and sensors for homeland security and defense markets, today
announced the inception of a pilot program supported by East Coast
Implant Sciences Corporation (OTCPK:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced the inception of a pilot program supported by East Coast Airport Services (ECAS) which provides a broad and diverse range of services to the aviation industry including air cargo screening services. The program will be conducted in ECAS’s air cargo screening facilities at Boston Logan International Airport. The agreement to conduct the pilot program was facilitated by the Port Authority of Massachusetts (Massport) who introduced Implant Sciences and its technologies to ECAS and other stakeholders in aviation, seaport, and transportation infrastructure security. “This program will allow for the collection of key operational data in the fast paced real-world of air cargo screening. This will offer critical insight to the Company and its customers as they develop effective and efficient operational protocols to satisfy the requirements of US Public Law 110-53 ‘‘Implementing Recommendations of the 9/11 Commission Act of 2007,”” said Todd Silvestri, Vice President of Technology for Implant Sciences. Silvestri added, “This pilot program, combined with ongoing verification and validation activities and the recent Department of Homeland Security SAFETY Act designation of the Quantum Sniffer as a Qualified Anti-Terrorism Technology, will help to ensure the Company’s success in Air Cargo Screening markets.” Glenn D. Bolduc, CEO, commented, “Implant Sciences is excited to have the opportunity to evaluate our technologies in a world class air cargo screening facility with the challenging environmental conditions that are presented there.” Mr. Bolduc continued, “The Company would like to thank ECAS for this opportunity which, in parallel to the evaluation currently underway within the TSA’s Air Cargo Screening Qualification Test, will ultimately help the Company achieve its goal of delivering superior technologies exceeding customer expectations.” About Implant Sciences Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive trace detection systems which ship to a growing number of locations domestically and internationally. For further details on the Company and its products, please visit the Company's website at www.implantsciences.com. Safe Harbor Statement This press release may contain certain “forward-looking statements,” as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management’s current expectations and are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the U.S. government or by other law enforcement agencies or commercial consumers of security products; our business is subject to intense competition and rapid technological change; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.